Retrospective study of a series of 26 carcinomatous meningitis secondary to lung cancer;Étude rétrospective d'une série de 26 cas de méningite carcinomateuse secondaire à un cancer bronchique

Bulletin du Cancer

Volumn 92, Issue 11, 2005, Pages 989-994

  Hammerer, Valérie ^a   Pauli, Gabrielle ^a   Quoix, Élisabeth ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Cerebrospinal fluid; Intrathecal chemotherapy; Lung cancer; Meningeal carcinomatosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MALE; MOLECULE; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR CELL; ADENOCARCINOMA; COHORT ANALYSIS; CYTOLOGY; INTRASPINAL DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MENINGIOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENT; METHOTREXATE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CEREBROSPINAL FLUID; COHORT STUDIES; FEMALE; HUMANS; INJECTIONS, SPINAL; LUNG NEOPLASMS; MALE; MENINGEAL NEOPLASMS; METHOTREXATE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 29344459192     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Yap HY, Yap BS, Tashima CK, DiStefano A, Blumenschein GR. Meningeal carcinomatosis in breast cancer. Cancer 1978; 42: 283-6.
2. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978; 42: 660-8.
3. Nugent JL, Bunn PA, Matthews MJ, et al. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 1979; 44: 1885-93.
4. Aroney RS, Dalley DN, Chan WK, Bell DR, Levi JA. Meningeal carcinomatosis in small cell carcinoma of the lung. Am J Med 1981; 71: 26-32.
5. Blanchon F, Grivaux M, Collon T, et al. Epidémiologie du cancer bronchique primitif pris en charge dans les centres hospitaliers généraux français. Rev Mal Respir 2002; 19: 727-34.
6. Chamberlain MC, Kormanik P. Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy. Arch Neurol 1998; 55: 506-12.
7. Chamberlain MC, Kormanik P, Jaeckle KA, Glantz M. 111Indium- diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology 1999; 52: 216-7.
8. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982; 49: 759-72.
9. Hiesiger EM, Picco-Del Bo A, Lipschutz LE, et al. Experimental meningeal carcinomatosis selectively depresses local cerebral glucose utilization in rat brain. Neurology 1989; 39: 90-5.
10. Siegal T, Mildworf B, Stein D, Melamed E. Leptomeningeal metastases: reduction in regional cerebral blood flow and cognitive impairment. Ann Neurol 1985; 17: 100-2.
11. Theodore WH, Gendelman S. Meningeal carcinomatosis. Arch Neurol 1981; 38: 696-9.
12. Gonzalez-Vitale JC, Garcia-Bunuel R. Meningeal carcinomatosis. Cancer 1976; 37: 2906-11.
13. Little JR, Dale AJ, Okazaki H. Meningeal carcinomatosis: clinical manifestations. Arch Neurol 1974; 30: 138-43.
14. Balm M, Hammack J. Leptomeningeal carcinomatosis: presenting features and prognostic factors. Arch Neurol 1996; 53: 626-32.
15. Reuler JB, Meier D. Leptomeningeal carcinomatosis with normal CSF features. Arch Intern Med 1979; 139: 237-8.
16. Glantz MJ, Cole BF, Glantz LK, et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 1998; 82: 733-9.
17. DeAngelis LM. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998; 38: 245-52.
18. Schipper HI, Bardosi A, Jacobi C, Felgenhauer K. Meningeal carcinomatosis: origin of local IgG production in the CSF. Neurology 1988; 38: 413-6.
19. Schumacher M, Orszagh M. Imaging techniques in neoplastic meningiosis. J Neurooncol 1998; 38: 111-20.
20. Chamberlain MC. Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers. Neurology 1998; 50: 1173-5.
21. Blaney SM, Poplack DG. New cytotoxic drugs for intrathecal administration. J Neurooncol 1998; 38: 219-23.
22. Tsuchiya K, Katase S, Yoshino A, Hachiya J. FLAIR MR imaging for diagnosing intracranial meningeal carcinomatosis. Am J Roentgenol 2001; 176: 1585-8.
23. Grossman SA, Trump DL, Chen DC, Thompson G, Camargo EE. Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis: an evaluation using 111indium-DTPA ventriculography. Am J Med 1982; 73: 641-7.
24. Chamberlain MC. Radioisotope CSF flow studies in leptomeningeal metastases. J Neurooncol 1998; 38: 135-40.
25. Kokkoris CP. Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid? Cancer 1983; 51: 154-60.
26. Mechleb B, Khater F, Eid A, David G, Moorman JP. Late onset Ommaya reservoir infection due to Staphylococcus aureus: case report and review of Ommaya Infections. J Infect 2003; 46: 196-8.
27. Grant R, Naylor B, Greenberg HS, Junck L. Clinical outcome in aggressively treated meningeal carcinomatosis. Arch Neurol 1994; 51: 457-61.
28. Walker RW, Allen JC, Rosen G, Caparros B. Transient cerebral dysfunction secondary to high-dose methotrexate. J Clin Oncol 1986; 4: 1845-50.
29. Weiss S, Kahn Y. Intrathecal methotrexate causing paraplegia in a middle-aged woman. Acta Haematol 1978; 60: 59-61.
30. Rubinstein LJ, Herman MM, Long TF, Wilbur JR. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 1975; 35: 291-305.
31. Mehta BM, Glass JP, Shapiro WR. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis. Cancer Res 1983; 43: 435-8.
32. Sostman HD, Matthay RA, Putman CE, Smith GJ. Methotrexate-induced pneumonitis. Medicine (Baltimore) 1976; 55: 371-88.
33. Alkins SA, Byrd JC, Morgan SK, Ward FT, Weiss RB. Anaphylactoid reactions to methotrexate. Cancer 1996; 77: 2123-6.
34. Hamous JE, Guffy MM, Aschenbrener CA. Fatal acute respiratory failure following intrathecal methotrexate administration. Cancer Treat Rep 1983; 67: 1025-6.
35. Shapiro WR, Young DF, Mehta BM. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975; 293: 161-6.
36. Hitchins RN, Bell DR, Woods RL, Levi JA. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 1987; 5: 1655-62.
37. Jaeckle KA, Batchelor T, O'Day SJ, et al. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol 2002; 57: 231-9.
38. Glantz MJ, Jaeckle KA, Chamberlain MC, et al. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 1999; 5: 3394-402.
39. Cole BF, Glantz MJ, Jaeckle KA, Chamberlain MC, Mackowiak JI. Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis. Cancer 2003; 97: 3053-60.
40. Chen YM, Chen MC, Tsai CM, Perng RP. Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis: a case report. Lung Cancer 2003; 40: 99-101.